FDA Approves New Drug to Reduce Risk of Stroke

Circulation - United States
doi 10.1161/01.cir.101.3.e41
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

FDA Approves Test for TB

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
1997English

FDA Approves First Biosimilar to Treat Cancer

Cancer Discovery
Oncology
2017English

FDA Approves Kadcyla for Breast Cancer

Cancer Discovery
Oncology
2013English

FDA Approves Second Vaccine to Protect Children Against Rotaviruses

Microbe
Microbiology
2008English

Automated Software System to Promote Anticoagulation and Reduce Stroke Risk

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2017English

FDA Approves Breakthrough Immunotherapy for Patients With Non-Small-Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Legislation Introduced to Create a New Drug Safety Office at the FDA

BMJ
2005English

New FDA Drug Approval Policies and HIV Vaccine Development.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1990English

2017 FDA Drug Approvals

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy